Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Pharma Commercial Excellence in CEE, CIS, SEE & Turkey

04 Oct 2012 - 05 Oct 2012 - Budapest, Hungary



Bookmark and Share


At this 2-day event attendees will have a unique chance to interact with the pharmaceutical specialists from concerned regions. The representatives from AstraZeneca, Sanofi, Merck, Novartis, Teva etc. will share their best practices in the form of presentations and case studies. 

During the 2-stream program on both days, 20 experts speakers will provide participants with governmental perspective, industry and regulatory insights, and physicians' and payers' perspectives. 

The special block, involved into the first conference day, will bring the deeper insight into the HTA processes throughout the regions. Russian, Slovak, Serbian, Polish, Swedish and Turkish perspectives will be introduced.

How to maintain and maximize competitive advantage in the region? How to optimize interactions between the key stakeholders? What are the ways to predict and meet customer needs? These are only few of many questions that will be answered at Fleming Europe's conference.

For more information request the detailed agenda http://pharma.flemingeurope.com/pharma-excellence/request-agenda




Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!